KR102547559B1 - 엘리글루스타트의 합성방법 및 그 중간체 화합물 - Google Patents

엘리글루스타트의 합성방법 및 그 중간체 화합물 Download PDF

Info

Publication number
KR102547559B1
KR102547559B1 KR1020197030823A KR20197030823A KR102547559B1 KR 102547559 B1 KR102547559 B1 KR 102547559B1 KR 1020197030823 A KR1020197030823 A KR 1020197030823A KR 20197030823 A KR20197030823 A KR 20197030823A KR 102547559 B1 KR102547559 B1 KR 102547559B1
Authority
KR
South Korea
Prior art keywords
compound
protecting group
hydroxy protecting
hydrogen
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020197030823A
Other languages
English (en)
Korean (ko)
Other versions
KR20190140927A (ko
Inventor
유 리우
구아넹 유
지구오 젱
Original Assignee
저장 아우선 파마슈티칼 씨오., 엘티디.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 저장 아우선 파마슈티칼 씨오., 엘티디. filed Critical 저장 아우선 파마슈티칼 씨오., 엘티디.
Publication of KR20190140927A publication Critical patent/KR20190140927A/ko
Application granted granted Critical
Publication of KR102547559B1 publication Critical patent/KR102547559B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/24—Preparation of compounds containing amino groups bound to a carbon skeleton by reductive alkylation of ammonia, amines or compounds having groups reducible to amino groups, with carbonyl compounds
    • C07C209/26—Preparation of compounds containing amino groups bound to a carbon skeleton by reductive alkylation of ammonia, amines or compounds having groups reducible to amino groups, with carbonyl compounds by reduction with hydrogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
KR1020197030823A 2017-03-21 2017-10-16 엘리글루스타트의 합성방법 및 그 중간체 화합물 Active KR102547559B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201710169305.9A CN106967042B (zh) 2017-03-21 2017-03-21 依利格鲁司他的合成方法及其中间体化合物
CN201710169305.9 2017-03-21
PCT/CN2017/106348 WO2018171173A1 (zh) 2017-03-21 2017-10-16 依利格鲁司他的合成方法及其中间体化合物

Publications (2)

Publication Number Publication Date
KR20190140927A KR20190140927A (ko) 2019-12-20
KR102547559B1 true KR102547559B1 (ko) 2023-06-26

Family

ID=59329206

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020197030823A Active KR102547559B1 (ko) 2017-03-21 2017-10-16 엘리글루스타트의 합성방법 및 그 중간체 화합물

Country Status (10)

Country Link
US (2) US9988364B1 (https=)
EP (2) EP4417605A3 (https=)
JP (2) JP7098651B2 (https=)
KR (1) KR102547559B1 (https=)
CN (2) CN106967042B (https=)
ES (1) ES2986115T3 (https=)
HR (1) HRP20241128T1 (https=)
HU (1) HUE068098T2 (https=)
PT (1) PT3611171T (https=)
WO (1) WO2018171173A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106967042B (zh) 2017-03-21 2020-08-14 浙江奥翔药业股份有限公司 依利格鲁司他的合成方法及其中间体化合物
US20200306225A1 (en) * 2017-10-27 2020-10-01 Msn Laboratories Private Limited, R&D Center Stable n-((1r,2r)-1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl) octanamide (2r,3r)-2,3-dihydroxysuccinate premix and process for preparation thereof
WO2020020365A1 (zh) * 2018-07-27 2020-01-30 中国医学科学院药物研究所 制备光活依格鲁特的方法
CN110759885B (zh) * 2018-07-27 2021-10-22 中国医学科学院药物研究所 制备光活依格鲁特的方法
CN110878079A (zh) * 2018-12-31 2020-03-13 北京启慧生物医药有限公司 一种高纯度依利格鲁司他的制备方法
CN110256321B (zh) * 2019-06-12 2021-05-28 山东省医学科学院药物研究所（山东省抗衰老研究中心、山东省新技术制药研究所） (2r,3s,4s)-4-氨基-2-十四烷基吡咯烷-3-醇的制备方法及其应用
CN113893346B (zh) * 2020-06-22 2022-11-18 四川大学华西医院 Gcs抑制剂在制备治疗可卡因成瘾的药物中的用途
CN112125805B (zh) * 2020-09-11 2022-10-18 北京红惠新医药科技有限公司 水溶性厚朴酚衍生物及和厚朴酚衍生物和其中间体的制备方法、和相关的单羟基保护中间体
CN113880819B (zh) * 2021-09-18 2024-09-20 浙江大学医学院附属第一医院 立他司特的制备方法及其中间体化合物
CN114456089B (zh) * 2022-03-29 2023-05-23 南昌航空大学 一种路易斯酸促进的烯烃和肟酯与胺的三组分反应方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003008399A1 (en) * 2001-07-16 2003-01-30 Genzyme Corporation Synthesis of udp-glucose: n-acylsphingosine glucosyltransferase inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104557851B (zh) * 2015-02-10 2017-04-05 苏州明锐医药科技有限公司 依鲁司他的制备方法
WO2017068496A1 (en) 2015-10-20 2017-04-27 Dr. Reddy' S Laboratories Limited Improved process for the preparation of eliglustat and its salts
CN105646442A (zh) * 2015-10-27 2016-06-08 北京凯莱天成医药科技有限公司 一种依利格鲁司他的制备方法
CN106349210A (zh) 2016-08-24 2017-01-25 北京阳光诺和药物研究有限公司 一种制备酒石酸艾力骨司坦的方法
CN106349310B (zh) 2016-08-26 2019-06-11 内蒙古嘉宝仕生物科技股份有限公司 甲氨基阿维菌素苯甲酸盐的制备方法
CN106967042B (zh) * 2017-03-21 2020-08-14 浙江奥翔药业股份有限公司 依利格鲁司他的合成方法及其中间体化合物

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003008399A1 (en) * 2001-07-16 2003-01-30 Genzyme Corporation Synthesis of udp-glucose: n-acylsphingosine glucosyltransferase inhibitors

Also Published As

Publication number Publication date
ES2986115T3 (es) 2024-11-08
JP2022058564A (ja) 2022-04-12
CN106967042A (zh) 2017-07-21
EP3611171A1 (en) 2020-02-19
US11697644B2 (en) 2023-07-11
JP7307823B2 (ja) 2023-07-12
EP4417605A3 (en) 2025-03-12
CN106967042B (zh) 2020-08-14
HRP20241128T1 (hr) 2024-11-22
WO2018171173A1 (zh) 2018-09-27
JP7098651B2 (ja) 2022-07-11
US20200031808A1 (en) 2020-01-30
CN110461826A (zh) 2019-11-15
PT3611171T (pt) 2024-09-04
EP3611171B1 (en) 2024-06-12
KR20190140927A (ko) 2019-12-20
US9988364B1 (en) 2018-06-05
HUE068098T2 (hu) 2024-12-28
CN110461826B (zh) 2023-08-25
JP2020511508A (ja) 2020-04-16
EP4417605A2 (en) 2024-08-21
EP3611171A4 (en) 2021-03-03

Similar Documents

Publication Publication Date Title
KR102547559B1 (ko) 엘리글루스타트의 합성방법 및 그 중간체 화합물
EP2927231B1 (en) Imidazopyridine compounds
EP2297112B1 (en) Pyrazole compounds as ccr1 antagonists
JP6279605B2 (ja) 自己免疫疾患および炎症性疾患の処置に使用するためのレチノイド関連オーファン受容体ガンマ（ＲＯＲγ）のモジュレーター
KR101397352B1 (ko) 4-치환된 페녹시페닐아세트산 유도체
JP7090770B2 (ja) Ｅｐ４アンタゴニスト
ES2401052T3 (es) Derivados éster como inhibidores de fosfodiesterasa
NL1029726C2 (nl) Triazolopyridinylsulfanylderivaten als remmers van p38-MAP-kinase.
TWI905393B (zh) 經三唑基-甲基取代的α-D-吡喃半乳糖苷衍生物
BRPI0413991B1 (pt) composto ativador de ppar e composição farmacêutica contendo o mesmo
JP2024503855A (ja) アミノピリミジン系ｆａｋ阻害剤化合物を合成する方法
CA2693552A1 (en) Pyridone compound
BRPI0611435A2 (pt) derivados de 2-amido-6-amino-8-oxopurina, composições farmacêuticas, uso e processo de preparo dos mesmos
WO1996032384A1 (en) Novel 4,6-diarylpyrimidine derivatives and salts thereof
ES2394480T3 (es) Derivado de isoxazolina y nuevo procedimiento para su preparación
JP3213327B2 (ja) ベンゾチアゾロン誘導体
WO2025033387A1 (ja) 糖脂質誘導体の製造法及びそれらの合成中間体並びにその結晶体
RU2761341C2 (ru) Антагонисты ер4
JPWO2014199960A1 (ja) グリシントランスポーター阻害物質
JP2021095367A (ja) Ｃ−アリールグリコシド誘導体の製造方法
JPWO2001007031A1 (ja) ベンゼン誘導体およびそれを含有する免疫賦活性組成物または薬剤感受性回復剤
ES2351574A1 (es) Bibliotecas de n-fenetisulfonamidas-n-sustituidas para el descubrimiento de farmacos.
KR20090112980A (ko) 메틸이소제람블론의 제조방법 및 이를 위한 중간체

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20191018

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
AMND Amendment
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20201014

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20220728

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20230117

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20220728

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

X091 Application refused [patent]
AMND Amendment
PX0901 Re-examination

Patent event code: PX09011S01I

Patent event date: 20230117

Comment text: Decision to Refuse Application

Patent event code: PX09012R01I

Patent event date: 20220920

Comment text: Amendment to Specification, etc.

Patent event code: PX09012R01I

Patent event date: 20201014

Comment text: Amendment to Specification, etc.

PX0701 Decision of registration after re-examination

Patent event date: 20230502

Comment text: Decision to Grant Registration

Patent event code: PX07013S01D

Patent event date: 20230403

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

Patent event date: 20230117

Comment text: Decision to Refuse Application

Patent event code: PX07011S01I

Patent event date: 20220920

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

Patent event date: 20201014

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

X701 Decision to grant (after re-examination)
GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20230621

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20230622

End annual number: 3

Start annual number: 1

PG1601 Publication of registration